Issue 4/2022
Content (15 Articles)
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
Sarina B. Elmariah, Jeffrey S. Smith, Joseph F. Merola
Time to Relapse After Discontinuing Systemic Treatment for Psoriasis: A Systematic Review
Marie Masson Regnault, Jason Shourick, Fatma Jendoubi, Marie Tauber, Carle Paul
Methotrexate Cutaneous Ulceration: A Systematic Review of Cases
Ronald Berna, Misha Rosenbach, David J. Margolis, Nandita Mitra, Emily Baumrin
Evaluating the Longitudinal Course of Atopic Dermatitis: Implications for Clinical Practice
Raj Chovatiya, Jonathan I. Silverberg
Candida Infection Associated with Anti-IL-17 Medication: A Systematic Analysis and Review of the Literature
Mika Yamanaka-Takaichi, Soha Ghanian, David A. Katzka, Rochelle R. Torgerson, Afsaneh Alavi
Cutaneous Manifestations of Inflammatory Bowel Disease: A Basic Overview
Kyla Pagani, Danitza Lukac, Aashni Bhukhan, Jean S. McGee
The Evolving Landscape of Cutaneous Sarcoidosis: Pathogenic Insight, Clinical Challenges, and New Frontiers in Therapy
Julie H. Wu, Sotonye Imadojemu, Avrom S. Caplan
Melanoma Brain Metastases: An Update on the Use of Immune Checkpoint Inhibitors and Molecularly Targeted Agents
Stergios J. Moschos
Tralokinumab Plus Topical Corticosteroids as Needed Provides Progressive and Sustained Efficacy in Adults with Moderate-to-Severe Atopic Dermatitis Over a 32-Week Period: An ECZTRA 3 Post Hoc Analysis
Jonathan I. Silverberg, David N. Adam, Matthew Zirwas, Sunil Kalia, Jan Gutermuth, Andreas Pinter, Andrew E. Pink, Andrea Chiricozzi, Sebastien Barbarot, Thomas Mark, Ann-Marie Tindberg, Stephan Weidinger
Chlormethine Gel Versus Chlormethine Ointment for Treatment of Patients with Mycosis Fungoides: A Post-Hoc Analysis of Clinical Trial Data
Christiane Querfeld, Julia J. Scarisbrick, Chalid Assaf, Youn H. Kim, Joan Guitart, Pietro Quaglino, Emmilia Hodak
Clinical Effectiveness and Safety of Initial Combination Therapy with Corticosteroids and Rituximab in Bullous Pemphigoid: A Retrospective Cohort Study
Yun-Ju Tsai, Yung-Tsu Cho, Chia-Yu Chu
Oncodermatology: Advancing the Science and Care of Cancer Patients and Survivors
Alexander S. Bang, Milan J. Anadkat, Jennifer N. Choi, Nicole R. LeBoeuf, Jae Y. Jung, Alina Markova, Allison Gordon, Anthony M. Rossi, Sarah J. Noor, Vincent Sibaud, Mario E. Lacouture
Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”
Mafalda Pestana, Margarida Brito Caldeira, Joana Cabete
Author’s Reply to Pestana et al. Comment on: “Is There a Role for Therapeutic Drug Monitoring in Patients with Hidradenitis Suppurativa on Tumor Necrosis Factor-α Inhibitors?”
Afsaneh Alavi, Laura Raffals